Study in Neuropathic Pain Patients With Peripheral Nerve Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Pain, Neuropathic
Interventions
DRUG

GW856553

GW856553 is a film coated white tablet, 9mm round, biconvex, plain faced. It will be administered 7.5mg bid, orally with food at breakfast and dinner.

DRUG

PLACEBO

Matching Placebo is a film coated white tablet, 9mm round, biconvex, plain faced. It will be administered orally with food at breakfast and dinner.

Trial Locations (23)

2065

GSK Investigational Site, St Leonards

2292

GSK Investigational Site, Broadmeadow

3103

GSK Investigational Site, Tønsberg

5000

GSK Investigational Site, Odense C

7030

GSK Investigational Site, Trondheim

8000

GSK Investigational Site, Aarhus C

18014

GSK Investigational Site, Granada

28006

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

32005

GSK Investigational Site, Ourense

117292

GSK Investigational Site, Moscow

150030

GSK Investigational Site, Yaroslavl

420021

GSK Investigational Site, Kazan'

664003

GSK Investigational Site, Irkutsk

Unknown

GSK Investigational Site, Koebenhavn NV

0027

GSK Investigational Site, Oslo

0514

GSK Investigational Site, Oslo

08916

GSK Investigational Site, Badalona

08036

GSK Investigational Site, Barcelona

SE-413 45

GSK Investigational Site, Gothenburg

SE-581 85

GSK Investigational Site, Linköping

SE-115 22

GSK Investigational Site, Stockholm

W12 0NN

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00969059 - Study in Neuropathic Pain Patients With Peripheral Nerve Injury | Biotech Hunter | Biotech Hunter